MktsMarkets

BioMarin Pharmaceutical Inc.
NASDAQ: BMRNKey statistics
BMRN News
Stories mentioning BMRN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 766,208 | 874,565 | 776,133 | 825,410 | 745,145 | 747,313 | 745,740 | 712,029 |
| Cost of Goods Sold | 194,999 | 275,709 | 140,085 | 150,090 | 151,558 | 136,139 | 188,457 | 130,459 |
| Gross Profit | 571,209 | 598,856 | 636,048 | 675,320 | 593,587 | 611,174 | 557,283 | 581,570 |
| Operating Expenses | ||||||||
| Research & Development | 178,796 | 192,413 | 409,478 | 161,308 | 158,731 | 173,509 | 184,901 | 183,787 |
| Sales General & Admin | 258,290 | 446,207 | 268,415 | 232,279 | 206,116 | 266,607 | 253,480 | 263,032 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 129,640 | (44,610) | (46,692) | 276,887 | 223,893 | 161,407 | 113,893 | 120,452 |
| Interest Income | 22,560 | 19,210 | 17,854 | 18,827 | 19,013 | 17,680 | 18,053 | 19,785 |
| Interest Expense | 9,571 | 2,387 | ||||||
| Other Expense | ||||||||
| Pretax Income | 141,203 | (27,153) | (26,324) | 297,868 | 238,089 | 169,639 | 134,441 | 132,136 |
| Tax Provision | 35,676 | 19,420 | 4,420 | 57,336 | 52,403 | 44,696 | 28,361 | 24,962 |
| Net Income (Loss) | 105,527 | (46,573) | (30,744) | 240,532 | 185,686 | 124,943 | 106,080 | 107,174 |
| Earnings Per Share (Basic) | 0.55 | (0.24) | (0.16) | 1.25 | 0.97 | 0.66 | 0.56 | 0.56 |
| Earnings Per Share (Diluted) | 0.54 | (0.24) | (0.16) | 1.23 | 0.95 | 0.64 | 0.55 | 0.55 |
| Weighted Average Shares Outstanding (Basic) | 192,497 | 191,787 | 192,032 | 191,907 | 190,967 | 190,027 | 190,429 | 190,114 |
| Weighted Average Shares Outstanding (Diluted) | 197,671 | 197,394 | 192,032 | 197,091 | 196,474 | 196,708 | 197,147 | 200,505 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BMRN
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a stock listed on the Nasdaq Stock Market under the ticker symbol BMRN. It last traded at $57.35 (Nov 9, 2026, 3:35 PM ET), up 2.4% on the day. That gives BioMarin Pharmaceutical a market capitalisation of $10.9B and a price-to-earnings ratio of 153.9.
Over the past 52 weeks BMRN has traded between $49.26 and $70.98.
Revenue for the quarter ended Mar 31, 2026 was $766.2M; net income $105.5M. Revenue was up 2.8% from $745.1M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $766.2M | $105.5M | 13.8% |
| Dec 31, 2025 | $874.6M | -$46.6M | -5.3% |
| Sep 30, 2025 | $776.1M | -$30.7M | -4.0% |
| Jun 30, 2025 | $825.4M | $240.5M | 29.1% |
From BioMarin Pharmaceutical’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…